MC2019A1 - Composition pharmaceutique anti-hypertensive combinee - Google Patents

Composition pharmaceutique anti-hypertensive combinee

Info

Publication number
MC2019A1
MC2019A1 MC892041A MC2041A MC2019A1 MC 2019 A1 MC2019 A1 MC 2019A1 MC 892041 A MC892041 A MC 892041A MC 2041 A MC2041 A MC 2041A MC 2019 A1 MC2019 A1 MC 2019A1
Authority
MC
Monaco
Prior art keywords
pharmaceutical composition
combined anti
hypertensive pharmaceutical
formula
image
Prior art date
Application number
MC892041A
Other languages
English (en)
Inventor
Kleinbloesem Cornelis
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC2019A1 publication Critical patent/MC2019A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Materials By The Use Of Fluid Adsorption Or Reactions (AREA)
MC892041A 1988-03-24 1989-05-22 Composition pharmaceutique anti-hypertensive combinee MC2019A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH111488 1988-03-24

Publications (1)

Publication Number Publication Date
MC2019A1 true MC2019A1 (fr) 1990-02-23

Family

ID=4202814

Family Applications (1)

Application Number Title Priority Date Filing Date
MC892041A MC2019A1 (fr) 1988-03-24 1989-05-22 Composition pharmaceutique anti-hypertensive combinee

Country Status (13)

Country Link
EP (1) EP0334164B1 (fr)
JP (1) JPH01283224A (fr)
KR (1) KR890014116A (fr)
AT (1) ATE96322T1 (fr)
AU (1) AU616249B2 (fr)
CS (1) CS395291A3 (fr)
DE (1) DE58905990D1 (fr)
DK (1) DK140389A (fr)
HU (1) HU206612B (fr)
IL (1) IL89654A (fr)
MC (1) MC2019A1 (fr)
MX (1) MX9203171A (fr)
ZA (1) ZA892061B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2154277T3 (es) * 1993-07-15 2001-04-01 Hoffmann La Roche Combinacion farmaceutica que contiene un inhibidor del sistema renina-angiotensina y un antagonista de endotelina.
EP2537534B1 (fr) 2011-06-22 2014-12-17 Hexal AG Esters d'acide (1S,9S)-9-[[(1S)-1-carboxy-3-phénylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazépine-1-carboxylique et leur utilisation thérapeutique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW11586A1 (en) * 1985-07-01 1987-12-30 Hoffmann La Roche Bicyclic compounds
DE3542794A1 (de) * 1985-12-04 1987-06-11 Bayer Ag Antihypertensives kombinationspraeparat

Also Published As

Publication number Publication date
IL89654A (en) 1993-06-10
DK140389A (da) 1989-09-25
EP0334164A2 (fr) 1989-09-27
EP0334164B1 (fr) 1993-10-27
ATE96322T1 (de) 1993-11-15
HU206612B (en) 1992-12-28
AU3145689A (en) 1989-09-28
CS395291A3 (en) 1992-06-17
DE58905990D1 (de) 1993-12-02
ZA892061B (en) 1989-11-29
MX9203171A (es) 1992-07-01
AU616249B2 (en) 1991-10-24
IL89654A0 (en) 1989-09-28
HUT50281A (en) 1990-01-29
DK140389D0 (da) 1989-03-21
KR890014116A (ko) 1989-10-21
JPH01283224A (ja) 1989-11-14
EP0334164A3 (en) 1990-05-23

Similar Documents

Publication Publication Date Title
NO924172L (no) Substituerte bifenylpyridoner
ATE79619T1 (de) Arzneimittel.
AU7197387A (en) Novel styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxygenase inhibitors, pharmaceutical compositions and methods of use therefor
DE59000750D1 (de) Arzneimittel, enthaltend di-tert.-butylhydroxyphenyl-derivate sowie neue derivate.
CA2102697A1 (fr) Derives de pyrrolidine, leur preparation et les medicaments les contenant
GR3018182T3 (en) Derivatives of amidinophenylalanine, procedure for their preparation, their utilisation and anticoagulant compositions comprising them.
ATE110071T1 (de) Pyridazinon-derivate und diese enthaltende pharmazeutische zubereitungen.
AU4536389A (en) Anti-antherosclerotic diaryl compounds
IL84844A0 (en) Pharmaceutical compositions comprising a certain carbazolone derivative or a salt thereof
MC2019A1 (fr) Composition pharmaceutique anti-hypertensive combinee
AU1643592A (en) Novel compound and use of the same as medicine
IL76345A (en) Proline derivatives and antihypertensive and anti-glaucoma pharmaceutical preparations containing the same
NO883986D0 (no) Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter.
NO170936C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive, substituerte vinylcefalosporiner
DK0418990T3 (da) 13-brom- og 13,14-dibrom-ergoliner, deres fremstilling og anvendelse i lægemidler
GB1505518A (en) Pyrazole derivatives
IL105599A0 (en) Enantiomers derived from(s)-2-amino-2(3,4-dichlorobenzyl)-1-propanol and pharmaceutical compositions containing same
ITMI913461A0 (it) Composizioni terapeutiche adatte per la somministrazione rettale contenenti come principio attivo uno o piu' tioesteri del glutatione

Legal Events

Date Code Title Description
YP Annual fee paid